Efficacy and safety of neoadjuvant immunotherapy combined with chemoradiotherapy or chemotherapy in esophageal cancer: A systematic review and meta-analysis

BACKGROUND: Significant progress has been made in the investigation of neoadjuvant immune-chemoradiotherapy (NICRT) and neoadjuvant immune-chemotherapy (NICT) on the outcomes of esophageal cancer patients. To summarize the current developments, a systematic review and meta-analysis were conducted to...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yunsong, Bao, Yongxing, Yang, Xu, Sun, Shuang, Yuan, Meng, Ma, Zeliang, Zhang, Wanting, Zhai, Yirui, Wang, Yang, Men, Yu, Qin, Jianjun, Xue, Liyan, Wang, Jun, Hui, Zhouguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902949/
https://www.ncbi.nlm.nih.gov/pubmed/36761760
http://dx.doi.org/10.3389/fimmu.2023.1117448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902949/
https://www.ncbi.nlm.nih.gov/pubmed/36761760
http://dx.doi.org/10.3389/fimmu.2023.1117448

Ejemplares similares